Associate Professor, Oncology, Mayo Medical School
Oncology
Dr. Paul Haluska Jr., MD
|
|
Give Review
Doctor Paul Haluska Jr., MD practices Oncology. He went to medical school at Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74 in research and 67 in primary care medicine He over the years received 7 awards: "Mayo Clinic Ovarian SPORE Career Development Award", "Mayo Clinic Breast SPORE Career Development Award", "Young Investigator Award", "Paul Calabresi Program Career Development Award - K12", "Merit Award", "New Jersey Cancer Research Award for Scientific Excellence" and "Glaxo Wellcome Oncology Clinical Research Scholar Award". Paul Haluska Jr. is a published doctor. He published 18 publications, including: 'LBA1A Novel Neutralizing Antibody Targeting PAPP-A Inhibits Tumor Growth and Ascites in Primary Patient Ovarian Tumorgrafts (Ovatars).' Paul Haluska accepts Medicare payments and is listed with Medicare.gov.
Publications
- LBA1A Novel Neutralizing Antibody Targeting PAPP-A Inhibits Tumor Growth and Ascites in Primary Patient Ovarian TumorGrafts (Ovatars).
- A Novel Neutralizing Antibody Targeting Pregnancy-Associated Plasma Protein-A Inhibits Ovarian Cancer Growth and Ascites Accumulation in Patient Mouse Tumorgrafts.
- The Neoadjuvant Model is Still the Future for Drug Development in Breast Cancer.
- Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian Cancer.
- Pharmacokinetics of endoxifen and tamoxifen in female mice: implications for comparative in vivo activity studies.
- Phase I Dose-Escalation Study of MEDI-573, a Bispecific, Antiligand Monoclonal Antibody against IGFI and IGFII, in Patients with Advanced Solid Tumors.
- A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, Fallopian tube or primary peritoneal carcinoma.
- North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 rand...
- Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with ...
- Dual HER/VEGF Receptor Targeting Inhibits In Vivo Ovarian Cancer Tumor Growth.
- A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast Cancer.
- Developing Safety Criteria for Introducing New Agents into Neoadjuvant Trials.
- Intrathecal metastases causing conus medullaris syndrome.
- Adaptive Trials in the Neoadjuvant Setting: A Model to Safely Tailor Care While Accelerating Drug Development.
- An organ System based approach to prognosis in advanced melanoma.
- The insulin-like growth factor system in Cancer.
- Quantifying insulin receptor isoform expression in FFPE Breast tumors.
Schools
UmdnjRobert Wood Johnson Medical School
Mayo Grad School MedMayo Fndn
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
Awards
- Mayo Clinic Ovarian SPORE Career Development Award
- Mayo Clinic Breast SPORE Career Development Award
- Young Investigator Award
- Paul Calabresi Program Career Development Award - K12
- Merit Award
- New Jersey Cancer Research Award for Scientific Excellence
- Glaxo Wellcome Oncology Clinical Research Scholar Award
Education
-
Mayo School of Graduate Medical Education -
Rutgers Robert Wood Johnson Medical School
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Similar Doctors
|
|
Dr. Nadia N. Laack, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Brian A. Costello, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David A. Cook, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lynn C. Hartmann, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Pashtoon M. Kasi, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jann N. Sarkaria, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|